# PureTech Health appoints Robert Lyne as Chief Portfolio Officer

- Link: https://www.directorstalkinterviews.com/puretech-health-appoints-robert-lyne-as-chief-portfolio-officer/4121128347
- Published: 2023-09-27T07:27:14+01:00
- Author: Amilia Stone

**PureTech Health plc **(Nasdaq:PRTC, LON:PRTC), a clinical-stage biotherapeutics
company dedicated to changing the lives of patients with devastating diseases, has
announced the appointment of Robert Lyne as Chief Portfolio Officer. Robert brings
a decade of experience in international life science deals and portfolio management,
along with governance and executive team leadership experience.  Robert is expected
to join PureTech by early January 2024.

> “We are excited to welcome Rob to our management team and pleased to add a dedicated
> presence representing our senior leadership team in the UK as we work to deliver
> impactful new treatments for patients,” **said Daphne Zohar, Founder and Chief
> Executive Officer of PureTech**. “His extensive legal, operational and UK listed
> IP commercialization experience is complementary to PureTech’s own hub-and-spoke
> business model. We are looking forward to working together closely as we realize
> the full potential of both our Wholly Owned Programs and Founded Entity stakes
> and royalties.”

Mr. Lyne joins PureTech from Arix Bioscience plc, a transatlantic venture capital
company focused on investing in innovative biotechnology companies, where he served
as General Counsel and Chief Operating Officer before being appointed Chief Executive
Officer in April 2021. He began his career as a lawyer at international law firm
Bird & Bird LLP in London before moving to Touchstone Innovations, a London listed
biotech and technology investor, which was acquired in 2017. He has worked on over
80 venture capital financings in Europe and North America as well as multiple trade
exits and IPOs. As an experienced UK plc executive, Mr. Lyne has broad experience
formulating and implementing corporate strategy. Mr. Lyne has a BA from the University
of Oxford and an LLB from Oxford Brookes University.

> “I am delighted to be joining the management team at PureTech during such an exciting
> time in the Company’s growth,” **said Mr. Lyne.** “As pioneers of the hub-and-
> spoke model in the biotechnology sector, PureTech’s approach is aligned with my
> own experience and ambitions. They are highly innovative in their approach to 
> both science and business, which has led to the team delivering an impressive 
> track record of developing new therapies with transformational potential. I look
> forward to working with the skilled team at PureTech and its outstanding network
> of advisors to further drive the Company forward.”

Share on: